Celiac disease is diagnosed in those with genetic predisposition when serology identifies elevated anti-tTG, anti-endomysium, and deamidated gliadin peptide antibodies, and/or histology finds evidence of duodenal villous atrophy, intraepithelial lymphocytosis, and crypt hyperplasia. The gene discussed is TGM2; the disease is celiac disease.